Nagarsenker MS - Search Results

1

Liposomes: Advancements and innovation in the manufacturing process.

Shah S, Dhawan V, Holm R, Nagarsenker MS, Perrie Y. Shah S, et al. Among authors: nagarsenker ms. Adv Drug Deliv Rev. 2020;154-155:102-122. doi: 10.1016/j.addr.2020.07.002. Epub 2020 Jul 8. Adv Drug Deliv Rev. 2020. PMID: 32650041 Free article. Review.

2

Lecithin-based novel cationic nanocarriers (Leciplex) II: improving therapeutic efficacy of quercetin on oral administration.

Date AA, Nagarsenker MS, Patere S, Dhawan V, Gude RP, Hassan PA, Aswal V, Steiniger F, Thamm J, Fahr A. Date AA, et al. Among authors: nagarsenker ms. Mol Pharm. 2011 Jun 6;8(3):716-26. doi: 10.1021/mp100305h. Epub 2011 Apr 20. Mol Pharm. 2011. PMID: 21480639

3

Synthesis, characterization, and in vitro evaluation of palmitoylated arabinogalactan with potential for liver targeting.

Shah SM, Pathak PO, Jain AS, Barhate CR, Nagarsenker MS. Shah SM, et al. Among authors: nagarsenker ms. Carbohydr Res. 2013 Feb 15;367:41-7. doi: 10.1016/j.carres.2012.11.025. Epub 2012 Dec 8. Carbohydr Res. 2013. PMID: 23298829

4

Lipid colloidal carriers for improvement of anticancer activity of orally delivered quercetin: formulation, characterization and establishing in vitro-in vivo advantage.

Jain AS, Shah SM, Nagarsenker MS, Nikam Y, Gude RP, Steiniger F, Thamm J, Fahr A. Jain AS, et al. Among authors: nagarsenker ms. J Biomed Nanotechnol. 2013 Jul;9(7):1230-40. doi: 10.1166/jbn.2013.1636. J Biomed Nanotechnol. 2013. PMID: 23909137

5

Tamoxifen guided liposomes for targeting encapsulated anticancer agent to estrogen receptor positive breast cancer cells: in vitro and in vivo evaluation.

Jain AS, Goel PN, Shah SM, Dhawan VV, Nikam Y, Gude RP, Nagarsenker MS. Jain AS, et al. Among authors: nagarsenker ms. Biomed Pharmacother. 2014 May;68(4):429-38. doi: 10.1016/j.biopha.2014.03.004. Epub 2014 Mar 18. Biomed Pharmacother. 2014. PMID: 24721327

6

Preclinical formulations: insight, strategies, and practical considerations.

Shah SM, Jain AS, Kaushik R, Nagarsenker MS, Nerurkar MJ. Shah SM, et al. Among authors: nagarsenker ms. AAPS PharmSciTech. 2014 Oct;15(5):1307-23. doi: 10.1208/s12249-014-0156-1. Epub 2014 Jun 12. AAPS PharmSciTech. 2014. PMID: 24920522 Free PMC article. Review.

7

Apoptosis induction and anti-cancer activity of LeciPlex formulations.

Dhawan VV, Joshi GV, Jain AS, Nikam YP, Gude RP, Mulherkar R, Nagarsenker MS. Dhawan VV, et al. Among authors: nagarsenker ms. Cell Oncol (Dordr). 2014 Oct;37(5):339-51. doi: 10.1007/s13402-014-0183-7. Epub 2014 Sep 10. Cell Oncol (Dordr). 2014. PMID: 25204961

8

Liposomes for targeting hepatocellular carcinoma: use of conjugated arabinogalactan as targeting ligand.

Shah SM, Goel PN, Jain AS, Pathak PO, Padhye SG, Govindarajan S, Ghosh SS, Chaudhari PR, Gude RP, Gopal V, Nagarsenker MS. Shah SM, et al. Among authors: nagarsenker ms. Int J Pharm. 2014 Dec 30;477(1-2):128-39. doi: 10.1016/j.ijpharm.2014.10.014. Epub 2014 Oct 11. Int J Pharm. 2014. PMID: 25311181

9

Docetaxel in cationic lipid nanocapsules for enhanced in vivo activity.

Jain AS, Makhija DT, Goel PN, Shah SM, Nikam Y, Gude RP, Jagtap AG, Nagarsenker MS. Jain AS, et al. Among authors: nagarsenker ms. Pharm Dev Technol. 2016;21(1):76-85. doi: 10.3109/10837450.2014.971374. Epub 2014 Oct 20. Pharm Dev Technol. 2016. PMID: 25329444

10

Bolaamphiphiles: a pharmaceutical review.

Fariya M, Jain A, Dhawan V, Shah S, Nagarsenker MS. Fariya M, et al. Among authors: nagarsenker ms. Adv Pharm Bull. 2014 Dec;4(Suppl 2):483-91. doi: 10.5681/apb.2014.072. Epub 2014 Dec 31. Adv Pharm Bull. 2014. PMID: 25671179 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

80 results

Search Page